Bugworks was set up in 2014 & is incubated in C-CAMP, Bangalore. The core scientiﬁc team comes with a combined experience of over 200 years in Infection Drug Discovery. Bugworks engages with multiple globally reputed partners to propel its breakthrough broad spectrum assets.
Anti-bacterial lead generation has largely been impeded by the presence of eﬄux pumps. Bugworks has unlocked a strategy ELUDE™, to evade eﬄux pumps. ELUDE™ continues to provide multiple leads that are potent against Gram negative and Gram positive bacteria.
To create a huge value with the best-in-class products. To use our scientiﬁc prowess and business model to innovate, inspire, and implement solutions to combat AMR .